Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma

Abstract According to a number of studies, the occurrence and progression clear cell renal cell carcinoma (ccRCC), among the most prevalent cancerous tumors of the urinary bladder, may be inextricable from metabolism and immunology. The recent discovery of cuproptosis revealed a novel cell death mec...

Full description

Bibliographic Details
Main Authors: Dian Xia, Kun Liu, Wen Jiao, Longfei Peng, Qi Liu, Chang Liu, Liangkuan Bi
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:MedComm – Future Medicine
Subjects:
Online Access:https://doi.org/10.1002/mef2.36
_version_ 1797858707106693120
author Dian Xia
Kun Liu
Wen Jiao
Longfei Peng
Qi Liu
Chang Liu
Liangkuan Bi
author_facet Dian Xia
Kun Liu
Wen Jiao
Longfei Peng
Qi Liu
Chang Liu
Liangkuan Bi
author_sort Dian Xia
collection DOAJ
description Abstract According to a number of studies, the occurrence and progression clear cell renal cell carcinoma (ccRCC), among the most prevalent cancerous tumors of the urinary bladder, may be inextricable from metabolism and immunology. The recent discovery of cuproptosis revealed a novel cell death mechanism based on mitochondrial respiration and the tricarboxylic acid cycle, and cuproptosis is strongly linked to the metabolic process. The cuproptosis process is different from the previously revealed cell death processes such as pyroptosis, apoptosis and ferroptosis, which is expected to provide a new perspective in the study of tumor mechanism. Here we aim to explore the important role of key regulators of cuproptosis in renal cancer using a combination of bioinformatics and experimental validation. We found that Ferredoxin 1 (FDX1) was related to the infiltration of various immune cells in the tumor microenvironment and the response to immunotherapy in ccRCC. At the same time, the experiment confirmed that FDX1 was significantly lower in ccRCC, which was consistent with the previous analysis results. In conclusions, FDX1 was expected to be an important marker of immune infiltration, immunotherapy, and tumor prognosis in ccRCC.
first_indexed 2024-04-09T21:17:43Z
format Article
id doaj.art-b6f4cd6279234097886afd5e66f5e2bd
institution Directory Open Access Journal
issn 2769-6456
language English
last_indexed 2024-04-09T21:17:43Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series MedComm – Future Medicine
spelling doaj.art-b6f4cd6279234097886afd5e66f5e2bd2023-03-28T06:58:31ZengWileyMedComm – Future Medicine2769-64562023-03-0121n/an/a10.1002/mef2.36Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinomaDian Xia0Kun Liu1Wen Jiao2Longfei Peng3Qi Liu4Chang Liu5Liangkuan Bi6Department of Urology The Second Hospital of Anhui Medical University Hefei ChinaDepartment of Urology The Second Hospital of Anhui Medical University Hefei ChinaDepartment of Urology The Second Hospital of Anhui Medical University Hefei ChinaDepartment of Urology The Second Hospital of Anhui Medical University Hefei ChinaDepartment of Oncology The First Affiliated Hospital of Anhui Medical University Hefei ChinaDepartment of Urology The Second Hospital of Anhui Medical University Hefei ChinaDepartment of Urology The Second Hospital of Anhui Medical University Hefei ChinaAbstract According to a number of studies, the occurrence and progression clear cell renal cell carcinoma (ccRCC), among the most prevalent cancerous tumors of the urinary bladder, may be inextricable from metabolism and immunology. The recent discovery of cuproptosis revealed a novel cell death mechanism based on mitochondrial respiration and the tricarboxylic acid cycle, and cuproptosis is strongly linked to the metabolic process. The cuproptosis process is different from the previously revealed cell death processes such as pyroptosis, apoptosis and ferroptosis, which is expected to provide a new perspective in the study of tumor mechanism. Here we aim to explore the important role of key regulators of cuproptosis in renal cancer using a combination of bioinformatics and experimental validation. We found that Ferredoxin 1 (FDX1) was related to the infiltration of various immune cells in the tumor microenvironment and the response to immunotherapy in ccRCC. At the same time, the experiment confirmed that FDX1 was significantly lower in ccRCC, which was consistent with the previous analysis results. In conclusions, FDX1 was expected to be an important marker of immune infiltration, immunotherapy, and tumor prognosis in ccRCC.https://doi.org/10.1002/mef2.36bioinformatics engineeringclear cell renal cell carcinoma (ccRCC)cuproptosisFDX1tumor immunotherapytumor microenvironment
spellingShingle Dian Xia
Kun Liu
Wen Jiao
Longfei Peng
Qi Liu
Chang Liu
Liangkuan Bi
Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
MedComm – Future Medicine
bioinformatics engineering
clear cell renal cell carcinoma (ccRCC)
cuproptosis
FDX1
tumor immunotherapy
tumor microenvironment
title Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
title_full Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
title_fullStr Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
title_full_unstemmed Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
title_short Ferredoxin 1, the key regulator of cuproptosis, was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
title_sort ferredoxin 1 the key regulator of cuproptosis was associated with prognosis and immune cell infiltration in clear cell renal cell carcinoma
topic bioinformatics engineering
clear cell renal cell carcinoma (ccRCC)
cuproptosis
FDX1
tumor immunotherapy
tumor microenvironment
url https://doi.org/10.1002/mef2.36
work_keys_str_mv AT dianxia ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT kunliu ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT wenjiao ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT longfeipeng ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT qiliu ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT changliu ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma
AT liangkuanbi ferredoxin1thekeyregulatorofcuproptosiswasassociatedwithprognosisandimmunecellinfiltrationinclearcellrenalcellcarcinoma